Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment

Figure 5

Cancer immune activities positively correlate the sensitivity of cancer cells to PLK1 inhibitors (GW84368 and BI-2536). ssGSEA: the single-sample gene-set enrichment analysis.